Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 3Phase NA 1Phase 2/3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 8Recurrence 3Astrocytoma 3Gliosarcoma 2Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Pituitary Neoplasms 1Oligodendroglioma 1Non Small Cell Lung Cancer Metastatic 1Melanoma 1Medulloblastoma 1Glioma 1Ependymoma 1Brain Neoplasms 1Advanced Glioblastoma 1

Interventions

Vorinostat 1Temozolomide 1Saline Solution 1Pregabalin 1Minocycline 1Immunoglobulin G 1Esketamine 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Spinal Cord Neoplasms × Temozolomide × Clear all
NCT01236560 2024-02-20

Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma

National Cancer Institute (NCI)

Phase 2/3 Completed
101 enrolled 15 charts
CNS

Astrocytoma, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡